Odyssey Therapeutics, Inc.

Total Valuation

Odyssey Therapeutics, Inc. carries a market capitalization of 869.86M, placing it among publicly traded companies globally.

Share Statistics

Odyssey Therapeutics, Inc. currently has 47.17M shares outstanding.

Financial Position

Odyssey Therapeutics, Inc. maintains a current ratio of 11.14, meaning it holds 11.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is -17.29, indicating conservative leverage, while an interest coverage ratio of -15,069.62 demonstrates limited ability to service its debt obligations.

Financial Efficiency

Taxes

Stock Price Statistics

Odyssey Therapeutics, Inc.'s stock has gained approximately 10.23143% over the past 52 weeks. The 50-day moving average sits at 22.25, while the 200-day moving average is 19.74.

Income Statement

Over the trailing twelve months, Odyssey Therapeutics, Inc. generated 4.63M in revenue and converted that into -115.60M in net income, yielding earnings per share of -4.19. EBITDA reached -120.56M, while operating income came in at -124.42M.

Cash Flow

Odyssey Therapeutics, Inc. produced -107.17M in operating cash flow over the past twelve months. After subtracting -1.22M in capital expenditures, free cash flow totaled -108.39M - equivalent to -3.93 per share.

Margins

Odyssey Therapeutics, Inc. operates with a gross margin of 100.00, reflecting its pricing power and cost economics. The operating margin of -2,686.01 and net profit margin of -2,495.73 provide insight into operational efficiency.

Dividends & Yields

The company's payout ratio of 0.78 indicates the proportion of earnings distributed to shareholders.